{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:47:12Z","timestamp":1792806432783,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Conjunctivitis, or inflammation of the conjunctiva, is a common condition that can be caused by infectious (eg, bacterial or viral infections) and noninfectious (eg, allergy) etiologies. Treatment involves diagnosis of the underlying cause and use of appropriate therapies. A broad-spectrum therapy that can address multiple etiologies, and also the accompanying inflammation, would be very useful. In this review, we discuss the usefulness of topical ophthalmic corticosteroids and ophthalmic formulations that combine corticosteroids with anti-infectives\/antibiotics for treating acute infectious conjunctivitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A review of the published literature and relevant treatment guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Topical corticosteroids are useful in treating ocular inflammation, but most treatment guidelines recommend steroid use generally in severe cases of conjunctivitis. This is partly due to risks associated with steroid use. These risks include potential for prolonging adenoviral infections and potentiating\/worsening herpes simplex virus infections, increased intraocular pressure, glaucoma, and cataracts. Most of these perceived risks are not, however, supported by high-quality clinical data. They are also associated with long-term steroid uses that are dissimilar to applications for infectious conjunctivitis. Clinical data show that ophthalmic formulations that combine corticosteroids with broad-spectrum anti-infectives could be effective and well tolerated when used for short-term treatment (\u22642 weeks).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Corticosteroids, in combination with anti-infectives, could be a promising treatment option for acute conjunctivitis subject to development of further evidence on their effectiveness and safety in conjunctivitis treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ico.0000000000001982","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:40:59Z","timestamp":1557160859000},"page":"1062-1067","source":"Crossref","is-referenced-by-count":70,"title":["Use of Topical Steroids in Conjunctivitis: A Review of the Evidence"],"prefix":"10.1097","volume":"38","author":[{"given":"Edward J.","family":"Holland","sequence":"first","affiliation":[{"name":"Cincinnati Eye Institute, Edgewood, KY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Fingeret","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, New York Harbor Health Care System, Brooklyn, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis S.","family":"Mah","sequence":"additional","affiliation":[{"name":"Departments of Cornea and External Diseases, Scripps Clinic Torrey Pines, La Jolla, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"R1-20230912","first-page":"544","article-title":"A comparison of eye problems in primary care and ophthalmology practices","volume":"23","author":"Shields","year":"1991","journal-title":"Fam Med."},{"key":"R2-20230912","first-page":"147","article-title":"Office visits to ophthalmologists and other physicians for eye care among the U.S. population, 1990","volume":"110","author":"Chiang","year":"1995","journal-title":"Public Health Rep."},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MAJ.0b013e3181637417","article-title":"Cost effectiveness of a point-of-care test for adenoviral conjunctivitis","volume":"336","author":"Udeh","year":"2008","journal-title":"Am J Med Sci."},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2415-9-13","article-title":"Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States","volume":"9","author":"Smith","year":"2009","journal-title":"BMC Ophthalmol."},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","article-title":"Acute bacterial conjunctivitis","volume":"86","author":"H\u00f8vding","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: a systematic review of diagnosis and treatment","volume":"310","author":"Azari","year":"2013","journal-title":"JAMA"},{"key":"R8-20230912","first-page":"1071","article-title":"Evidence-based treatment of acute infective conjunctivitis: breaking the cycle of antibiotic prescribing","volume":"55","author":"Visscher","year":"2009","journal-title":"Can Fam Physician"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jop.1993.9.157","article-title":"Intraocular pressure response to loteprednol etabonate in known steroid responders","volume":"9","author":"Bartlett","year":"1993","journal-title":"J Ocul Pharmacol."},{"key":"R12-20230912","first-page":"478","article-title":"Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes","volume":"36","author":"Clark","year":"1995","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaapos.2016.09.026","article-title":"Steroid-induced glaucoma in the pediatric population","volume":"21","author":"Nuyen","year":"2017","journal-title":"J AAPOS"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1444-0938.2002.tb03011.x","article-title":"What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts","volume":"85","author":"Jobling","year":"2002","journal-title":"Clin Exp Optom."},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archopht.1996.01100130573014","article-title":"The effects of corticosteroids of adenoviral replication","volume":"114","author":"Romanowski","year":"1996","journal-title":"Arch Ophthalmol."},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00003226-200204000-00010","article-title":"Topical corticosteroids of limited potency promote adenovirus replication in the Ad5\/NZW rabbit ocular model","volume":"21","author":"Romanowski","year":"2002","journal-title":"Cornea"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0886-3350(01)00863-X","article-title":"Topical ciprofloxacin-dexamethasone combination therapy after cataract surgery: randomized controlled clinical trial","volume":"27","author":"Mohan","year":"2001","journal-title":"J Cataract Refract Surg."},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/ICO.0b013e31815873c7","article-title":"Effects of loteprednol\/tobramycin versus dexamethasone\/tobramycin on intraocular pressure in healthy volunteers","volume":"27","author":"Holland","year":"2008","journal-title":"Cornea"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12325-012-0018-8","article-title":"Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis","volume":"29","author":"Belfort","year":"2012","journal-title":"Adv Ther."},{"key":"R22-20230912","first-page":"1239","article-title":"Netilmicin\/dexamethasone fixed combination in the treatment of conjunctival inflammation","volume":"7","author":"Faraldi","year":"2013","journal-title":"Clin Ophthalmol."},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/bjo.84.9.968","article-title":"Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1","volume":"84","author":"Uchio","year":"2000","journal-title":"Br J Ophthalmol."},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1185\/03007990903038269","article-title":"Acute conjunctivitis: truth and misconceptions","volume":"25","author":"O'Brien","year":"2009","journal-title":"Curr Med Res Opin."},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s40135-014-0046-4","article-title":"Management of acute conjunctivitis","volume":"2","author":"Segal","year":"2014","journal-title":"Curr Ophthalmol Rep."},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/13550280009006379","article-title":"Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal Herpes encephalitis","volume":"6","author":"Thompson","year":"2000","journal-title":"J Neurovirol."},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/joe.0.1750165","article-title":"Herpes simplex virus type 1 infection and glucocorticoid treatment regulate viral yield, glucocorticoid receptor and NF-\u03baB levels","volume":"175","author":"Erlandsson","year":"2002","journal-title":"J Endocrinol."},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/bjo.2010.188623","article-title":"A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis","volume":"95","author":"Wilkins","year":"2011","journal-title":"Br J Ophthalmol."},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-009-0062-1","article-title":"A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis","volume":"26","author":"Pelletier","year":"2009","journal-title":"Adv Ther."},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3109\/02713683.2014.964419","article-title":"Dexamethasone\/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial","volume":"40","author":"Pinto","year":"2015","journal-title":"Curr Eye Res."},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2018.05.012","article-title":"Randomized, controlled, phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"194","author":"Pepose","year":"2018","journal-title":"Am J Ophthalmol."},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/ICO.0b013e3181b765a6","article-title":"Preservative-free low-dose dexamethasone for the treatment of chronic ocular surface disease refractory to standard therapy","volume":"29","author":"Jonisch","year":"2010","journal-title":"Cornea"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICU.0000000000000437","article-title":"The use of povidone-iodine in ophthalmology","volume":"29","author":"Grzybowski","year":"2018","journal-title":"Curr Opin Ophthalmol."},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"xv","DOI":"10.1016\/j.ajo.2017.01.011","article-title":"The challenge of controlling infectious keratitis","volume":"176","author":"Oldenburg","year":"2017","journal-title":"Am J Ophthalmol."},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1167\/iovs.10-5944","article-title":"Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis","volume":"52","author":"Clement","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jcrs.2010.11.028","article-title":"In vitro efficacy of a povidone-iodine 0.4% and dexamethasone 0.1% suspension against ocular pathogens","volume":"37","author":"Pelletier","year":"2011","journal-title":"J Cataract Refract Surg."},{"key":"R41-20230912","article-title":"Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo"},{"key":"R45-20230912","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/bjo.64.6.430","article-title":"Intraocular pressure response to corticosteroids in children","volume":"64","author":"Biedner","year":"1980","journal-title":"Br J Ophthalmol."},{"key":"R46-20230912","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9394(14)76256-7","article-title":"Marked intraocular pressure response to instillation of corticosteroids in children","volume":"112","author":"Ohji","year":"1991","journal-title":"Am J Ophthalmol."},{"key":"R47-20230912","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0161-6420(97)30052-9","article-title":"Ocular-hypertensive response to topical steroids in children","volume":"104","author":"Kwok","year":"1997","journal-title":"Ophthalmology"},{"key":"R48-20230912","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0161-6420(00)00357-2","article-title":"Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon","volume":"107","author":"Ng","year":"2000","journal-title":"Ophthalmology"},{"key":"R49-20230912","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1442-9071.2005.01022.x","article-title":"Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial","volume":"33","author":"Lam","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"key":"R50-20230912","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3341\/kjo.2006.20.3.166","article-title":"Ocular hypertensive response to topical dexamethasone ointment in children","volume":"20","author":"Lee","year":"2006","journal-title":"Korean J Ophthalmol."},{"key":"R51-20230912","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9394(02)01701-4","article-title":"A controlled trial of povidone-iodine to treat infectious conjunctivitis in children","volume":"134","author":"Isenberg","year":"2002","journal-title":"Am J Ophthalmol."},{"key":"R52-20230912","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0002-9394(14)74560-X","article-title":"The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine","volume":"109","author":"Benevento","year":"1990","journal-title":"Am J Ophthalmol."},{"issue":"suppl 2","key":"R53-20230912","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000246027","article-title":"Inactivation of human viruses by povidone-iodine in comparison with other antiseptics","volume":"195","author":"Kawana","year":"1997","journal-title":"Dermatology"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003226-201908000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T14:52:20Z","timestamp":1694530340000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201908000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000001982","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,3]]}}}